Erdheim-Chester disease (ECD), also known as non-Langerhans cell histiocytosis, is a multi-systemic disease with unclear pathogenesis. Based on a small number of case studies, pegylated interferon-α (PEG-IFN-α) has been used as the front-line treatment option. However, there are limited data regarding administration of ropegylated-interferon α-2b (ROPEG-IFN-α 2b) for ECD patients. Herein, we report two cases of severe ECD treated with two types of PEG-IFN-α. One patient with heart and skeleton involvement and BRAF V600E mutation was treated with weekly PEG-IFN-α 2a. Another patient with bone involvement and no BRAF V600E mutation was administered monthly ROPEG-IFN-α 2b. The two types of PEG-IFN-α showed excellent disease control, excellent survival outcomes, and manageable toxicities in ECD patients. These results suggest that ROPEG-IFN-α 2b could be used equivalently to PEG-IFN-α 2a for management of advanced ECD.
Citations
Citations to this article as recorded by
An Autopsied Case of Erdheim-Chester Disease with Severe Cardiovascular Involvement Atsushi Matsunashi, Wang Zhipeng, Akihiko Sugimoto, Masakazu Fujimoto, Akihiko Yoshizawa, Ryo Sakamoto, Michihiro Uyama, Kohei Ikezoe, Kiminobu Tanizawa, Tomohiro Handa, Toyohiro Hirai Internal Medicine.2025;[Epub] CrossRef
Recent advances in therapeutic strategies of Erdheim-Chester disease Rohit Doke, Rahul Lokhande, Kalyani Chande, Kuldeep Vinchurkar, Bhupendra G. Prajapati Naunyn-Schmiedeberg's Archives of Pharmacology.2025;[Epub] CrossRef
Histiocytosis is an uncommon disease characterized by excessive accumulation of histiocytes. Here, we report a rare case of non-Langerhans-cell histiocytosis in a 51- year-old woman who presented with severe symptoms of pericardial effusion. Radiologic investigation also detected multiple bone (lower limbs, vertebrae, ribs, and ilium) lesions. Resected pericardium showed abundant mono- or multi-nucleated non-foamy histiocytes (CD68+/CD163+/S-100+/CD1α−/langerin−) in a fibroinflammatory background. The histiocytes demonstrated emperipolesis of lymphocytes, a hallmark feature of Rosai-Dorfman disease (RDD). However, molecular analysis revealed a BRAF V600E mutation of the proliferating histiocytes, highlighting the neoplastic features frequently observed in another non-Langerhans-cell histiocytosis known as Erdheim-Chester Disease (ECD). We consider this case to be a unique presentation of ECD harboring some RDD-like cells with emperipolesis, but not a case of RDD with a BRAF mutation concerning its clinical manifestation (involvement of the heart and bones) and neoplastic features.
Citations
Citations to this article as recorded by
An Autopsied Case of Erdheim-Chester Disease with Severe Cardiovascular Involvement Atsushi Matsunashi, Wang Zhipeng, Akihiko Sugimoto, Masakazu Fujimoto, Akihiko Yoshizawa, Ryo Sakamoto, Michihiro Uyama, Kohei Ikezoe, Kiminobu Tanizawa, Tomohiro Handa, Toyohiro Hirai Internal Medicine.2025;[Epub] CrossRef
Infantile Rosai-Dorfman Disease With Isolated Brain Lesions Disseminated to the Parenchyma and Intraventricular Ependyma, Alteration of Leukocytes as a Promotion Factor in Immune Defense, and New Proposals: A Case Report and Literature Review Nasser Kamalian, Shahmir Kamalian, Mohammad Vasei Cureus.2024;[Epub] CrossRef
Emperipolesis in pleural fluid mesothelial cells
. A phenomenon not associated with Rosai-Dorfman disease, report of a case
Diana Sofía Vargas-Lías, Mónica Lizette Serrano-Arévalo, Lara-Torres César, Corredor-Alonso Guillermo Ernesto, Hugo R. Dominguez-malagon Ultrastructural Pathology.2024; 48(5): 438. CrossRef
BRAF V600E mutation and high expression of PD-L1 in Rosai-Dorfman disease: case report and review of the literature Farnoush M. Moen, Mariam M. Youssef, Mihir Shukla, Mary Lynn Nierodzik, Marius E. Mayerhoefer, Christopher Park Journal of Hematopathology.2024; 17(4): 183. CrossRef
Characterizing Rosai-Dorfman disease with [18F]FDG PET/CT: a retrospective analysis of a single-center study Jianan Zhang, Ruixue Cui, Jian Li, Xinxin Cao, Yaping Luo European Radiology.2023; 33(9): 6492. CrossRef
Atypical skeletal involvement in patients with Erdheim–Chester disease: CT imaging findings Zaizhu Zhang, Wei Yu, Wenmin Guan, Qiang Lin, Ali Guermazi Orphanet Journal of Rare Diseases.2022;[Epub] CrossRef
BRAF mutation in overlapping form of Erdheim-Chester and Rosai Dorfman diseases: a unique case restricted to the central nervous system J. Dufour, B. Mathon, M. Touat, K. Hoang-Xuan, K. Mokhtari, A. Idbaih Revue Neurologique.2021; 177(6): 708. CrossRef
Reticulohistiocytoses: a revision of the full spectrum A. Bonometti, E. Berti Journal of the European Academy of Dermatology and Venereology.2020; 34(8): 1684. CrossRef
Orbital histiocytosis with systemic involvement Joaquín J.R. Civit, Davinia Godoy, Alicia Conde, Jorge Arencibia, Ramón Medel, Miguel A. Limeres, Iñigo S. Miguel, José D. Marín, Y. Aguilar, Francesc Tresserra, Francisco Medina Saudi Journal of Ophthalmology.2020; 34(4): 319. CrossRef
Coccidioidomycosis with emperipolesis in fine needle aspiration Alexandra Grosse, Claudia Grosse Cytopathology.2019; 30(4): 451. CrossRef
Bilateral Renal Colic as an Initial Presentation of Erdheim-Chester Disease Julien Sarkis, Fady Haddad, Sarah Nasr, Elie Hanna, Ahmad Mroueh, Elie Nemr Case Reports in Urology.2019; 2019: 1. CrossRef
Erdheim–Chester disease: description of two illustrative cases involving the lung Magda Zanelli, Maxwell Smith, Maria C Mengoli, Lucia Spaggiari, Loredana De Marco, Filippo Lococo, Francesco Puma, Stefano Ascani Histopathology.2018; 73(1): 167. CrossRef